Non-Invasive Testing to Evaluate Wound Healing in Diabetes
NCT: NCT04232631 · SUSPENDED
Brief Summary
Normal group: We will collect normative data from healthy individuals to include baseline data, screening, and images. Up to 500 people will be enrolled and can include normal healthy volunteers, staff and students/trainees. Data will be collected one time with no follow up. Patient group: We will prospectively collect data using one instrument (camera) (SnapshotNIR, Kent Imaging, Calgary, Alberta, Canada). We will collect non-contact imaging data before surgeries, during surgeries (if feasible), and during follow-up clinic visits. We will collect vascular data, demographic medical history, wound characteristics and measurements, frequency of debridement, off-loading, and clinic visits from existing medical records. We will collect lab data such as cultures glycosylated hemoglobin, hemoglobin and hematocrit, ESR, CRP and eGFR obtained per standard of care. Imaging with this device is research-only.
Frequently Asked Questions
What is Non-Invasive Testing to Evaluate Wound Healing in Diabetes?
Non-Invasive Testing to Evaluate Wound Healing in Diabetes is a clinical trial registered under NCT04232631. Current status: SUSPENDED.
What is the status of NCT04232631?
The current status of NCT04232631 (Non-Invasive Testing to Evaluate Wound Healing in Diabetes) is: SUSPENDED.
When did Non-Invasive Testing to Evaluate Wound Healing in Diabetes start?
Non-Invasive Testing to Evaluate Wound Healing in Diabetes started on 2021-04-28.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.